These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18446789)

  • 1. Hepatitis C virus infection: molecular pathways to metabolic syndrome.
    Sheikh MY; Choi J; Qadri I; Friedman JE; Sanyal AJ
    Hepatology; 2008 Jun; 47(6):2127-33. PubMed ID: 18446789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.
    Negro F; Sanyal AJ
    Liver Int; 2009 Mar; 29 Suppl 2():26-37. PubMed ID: 19187070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.
    Adinolfi LE; Durante-Mangoni E; Zampino R; Ruggiero G
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():52-5. PubMed ID: 16225474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
    Wedemeyer I; Bechmann LP; Odenthal M; Jochum C; Marquitan G; Drebber U; Gerken G; Gieseler RK; Dienes HP; Canbay A
    J Hepatol; 2009 Jan; 50(1):140-9. PubMed ID: 19019483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV infection and metabolic syndrome: which is the chicken and which is the egg?
    Negro F
    Gastroenterology; 2012 May; 142(6):1288-92. PubMed ID: 22537435
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
    Eguchi Y; Mizuta T; Ishibashi E; Kitajima Y; Oza N; Nakashita S; Hara M; Iwane S; Takahashi H; Akiyama T; Ario K; Kawaguchi Y; Yasutake T; Iwakiri R; Ozaki I; Hisatomi A; Eguchi T; Ono N; Fujimoto K
    Liver Int; 2009 Feb; 29(2):213-20. PubMed ID: 18710430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concluding remarks: metabolic syndrome, liver and HCV.
    Cortez-Pinto H
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():83-5. PubMed ID: 16225481
    [No Abstract]   [Full Text] [Related]  

  • 12. [HCV infection and liver steatosis].
    Cheng J; Zhang JQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):804-6. PubMed ID: 19958635
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic disorders and chronic viral disease: the case of HIV and HCV.
    Slama L; Le Camus C; Serfaty L; Pialoux G; Capeau J; Gharakhanian S
    Diabetes Metab; 2009 Feb; 35(1):1-11. PubMed ID: 19046914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus and glucose and lipid metabolism.
    Alaei M; Negro F
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C infection and diabetes.
    Noto H; Raskin P
    J Diabetes Complications; 2006; 20(2):113-20. PubMed ID: 16504840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Kinalska I; Gorska M
    Metabolism; 2008 Nov; 57(11):1539-44. PubMed ID: 18940391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
    Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.